Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantation
- 1 June 2001
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 34 (6) , 888-894
- https://doi.org/10.1016/s0168-8278(01)00039-3
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Incidence and clinical consequences of surface and polymerase gene mutations in liver transplant recipients on hepatitis B immunoglobulinHepatology, 1998
- Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis†Hepatology, 1998
- Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantationHepatology, 1998
- Prophylaxis in Liver Transplant Recipients Using A Fixed Dosing Schedule of Hepatitis B ImmunoglobulinHepatology, 1996
- Hepatitis B Virus Envelope Variation After Transplantation With and Without Hepatitis B Immune Globulin ProphylaxisHepatology, 1996
- Hepatitis B envelope protein mutantsThe Lancet, 1995
- Liver Transplantation in European Patients with the Hepatitis B Surface AntigenNew England Journal of Medicine, 1993
- Hepatitis B virus reinfection after orthotopic liver transplantation: Serological and clinical implicationsJournal of Hepatology, 1992
- Liver transplantation in HBs antigen (HBsAg) carriers: Prevention of hepatitis B virus (HBV) recurrence by passive immunizationJournal of Hepatology, 1991
- Passive immunoprophylaxis after liver transplantation in HBsAg-positive patientsThe Lancet, 1991